A pharmaceutical company accused of illegally using benefits to entice physicians to prescribe its dermatology drugs has settled those claims with the federal government for $3.5 million, the U.S. Attorney’s Office for the Eastern District of Pennsylvania has announced.

According to the settlement agreement, Spanish drugmaker Almirall, formerly known as Aqua Pharmaceuticals, will make the payment to resolve claims that between 2012 and 2017, it used its sales representatives and other employees to treat physicians to meals, entertainment, trips, gift cards and gifts to coax them into prescribing its drugs. Prosecutors also claim that Aqua hired doctors for speaking engagements, advisory boards and consulting services for the same reason. Almirall maintains executive offices in Exton.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]